High serum HTATIP2/TIP30 level in serous ovarian cancer as prognostic or diagnostic marker

KUMTEPE, Yakup; Halıcı, Zekai; SENGUL, Ozlem; Kunak, Celalettin Semih; Bayır, Yasin; Kilic, Nergiz; Çadırcı, Elif; PULUR, Alparslan; Bayraktutan, Zafer

doi:10.1186/2047-783x-18-18

Makale Tam Makale Uluslararası 2013

High serum HTATIP2/TIP30 level in serous ovarian cancer as prognostic or diagnostic marker

Yakup KUMTEPE, Zekai Halıcı, Ozlem SENGUL, Celalettin Semih Kunak, Yasin Bayır, Nergiz Kilic, Elif Çadırcı, Alparslan PULUR, Zafer Bayraktutan

EUROPEAN JOURNAL OF MEDICAL RESEARCH Cilt 18 · 24.06.2013

DOI ile aç

Özet

Background: Human HIV-1 TAT interactive protein 2 (HTATIP2/TIP30) is an evolutionarily conserved gene that is expressed ubiquitously in human tissues and some tumor tissues. This protein has been found to be associated with some gynecological cancers; as such, this study aimed to investigate blood HTATIP2/TIP30 levels in patients with ovarian cancer.

Sürdürülebilir Kalkınma Amaçları

SKA 3: Sağlıklı Bireyler

Atıf için künye

KUMTEPE, Y., Halıcı, Z., SENGUL, O., Kunak, C. S., Bayır, Y., Kilic, N., Çadırcı, E., PULUR, A., & Bayraktutan, Z. (2013). High serum HTATIP2/TIP30 level in serous ovarian cancer as prognostic or diagnostic marker. EUROPEAN JOURNAL OF MEDICAL RESEARCH, 18. https://doi.org/10.1186/2047-783x-18-18

BibTeX

@article{kumtepe2013-23638,
  author = {KUMTEPE, Yakup and Halıcı, Zekai and SENGUL, Ozlem and Kunak, Celalettin Semih and Bayır, Yasin and Kilic, Nergiz and Çadırcı, Elif and PULUR, Alparslan and Bayraktutan, Zafer},
  title = {High serum HTATIP2/TIP30 level in serous ovarian cancer as prognostic or diagnostic marker},
  journal = {EUROPEAN JOURNAL OF MEDICAL RESEARCH},
  year = {2013},
  volume = {18},
  issn = {0949-2321},
  doi = {10.1186/2047-783x-18-18},
  url = {https://akademik.atauni.edu.tr/yayinlar/23638-high-serum-htatip2tip30-level-in-serous-ovarian-cancer-as-prognostic-or}
}